Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check2 days agoChange DetectedThe page history shows a government funding notice being added and a revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check9 days agoChange DetectedUI enhancements to the history page include a Show glossary option, green highlights for additions, red highlights for deletions, and explanatory color-coding text; the revision label updates from v3.3.4 to v3.4.0.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe record history now shows a new revision entry: v3.3.4. The previous revision entry v3.3.3 has been removed from the list.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.3.3 is added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 entries are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange DetectedA new revision entry v3.3.2 was added to the record history, and the older v3.2.0 entry was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedThe government funding/operating status banner is removed from the page.SummaryDifference0.7%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.